11 results on '"Evans, Andrew H."'
Search Results
2. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours.
- Author
-
O'Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, Djamshidian A, Lees AJ, and Piccini P
- Subjects
- Aged, Brain Mapping, Compulsive Behavior complications, Compulsive Behavior diagnostic imaging, Corpus Striatum diagnostic imaging, Cues, Female, Humans, Impulsive Behavior complications, Impulsive Behavior diagnostic imaging, Male, Middle Aged, Parkinson Disease complications, Parkinson Disease diagnostic imaging, Radionuclide Imaging, Compulsive Behavior metabolism, Corpus Striatum metabolism, Dopamine metabolism, Impulsive Behavior metabolism, Parkinson Disease metabolism
- Abstract
Impulsive-compulsive behaviours are a significant source of morbidity for patients with Parkinson's disease receiving dopaminergic therapy. The development of these behaviours may reflect sensitization of the neural response to non-drug rewards, similar to that proposed for sensitization to drug rewards in addiction. Here, by using (11)C-raclopride positron emission tomography imaging, we investigated the effects of reward-related cues and L-dopa challenge in patients with Parkinson's disease with and without impulsive-compulsive behaviours on striatal levels of synaptic dopamine. Eighteen patients (11 with and seven without impulsive-compulsive behaviours) underwent three (11)C-raclopride positron emission tomography scans. The impulsive-compulsive behaviours included hypersexuality, binge eating, punding, compulsive use of dopamine replacement therapy, compulsive buying and pathological gambling, with eight patients exhibiting more than one impulsive-compulsive behaviour. There were no significant differences in baseline dopamine D2 receptor availability between the Parkinson's disease groups. No differences were found when comparing the percentage change of raclopride binding potential between the two Parkinson's disease groups following L-dopa challenge with neutral cues. The group with Parkinson's disease with impulsive-compulsive behaviours had a greater reduction of ventral striatum (11)C-raclopride binding potential following reward-related cue exposure, relative to neutral cue exposure, following L-dopa challenge (16.3% compared with 5.8% in Parkinson's disease controls, P = 0.016). The heightened response of striatal reward circuitry to heterogeneous reward-related visual cues among a group of patients with different impulsive-compulsive behaviours is consistent with a global sensitization to appetitive behaviours with dopaminergic therapy in vulnerable individuals. Our findings are relevant for the broader debate on the relation between impulsive-compulsive behaviours and addictions and may have important implications with regards to advertisement legislation in an effort to prevent the onset of behavioural addictions.
- Published
- 2011
- Full Text
- View/download PDF
3. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease.
- Author
-
Lim SY, O'Sullivan SS, Kotschet K, Gallagher DA, Lacey C, Lawrence AD, Lees AJ, O'Sullivan DJ, Peppard RF, Rodrigues JP, Schrag A, Silberstein P, Tisch S, and Evans AH
- Subjects
- Adolescent, Adult, Dopamine metabolism, Female, Health Care Surveys, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Movement Disorders etiology, Movement Disorders psychology, Parkinson Disease complications, Parkinson Disease psychology, Patient Compliance, Surveys and Questionnaires, Treatment Outcome, Young Adult, Deep Brain Stimulation adverse effects, Disruptive, Impulse Control, and Conduct Disorders etiology, Disruptive, Impulse Control, and Conduct Disorders psychology, Dopamine physiology, Neurosurgical Procedures adverse effects, Parkinson Disease surgery, Postoperative Complications psychology
- Abstract
Data regarding the effect of deep brain stimulation (DBS) surgery on the dopamine dysregulation syndrome (DDS), impulse control disorders (ICDs) and punding in Parkinson's disease (PD) are limited. We present a case series of 21 operated PD patients who had exhibited DDS, ICDs or punding at some stage during the disease. DDS remained unimproved or worsened post-operatively in 12/17 patients with pre-operative DDS (71%) (nine bilateral subthalamic nucleus [STN], one right-sided STN, two bilateral globus pallidus internus [GPi] DBS). DDS improved or resolved after bilateral STN DBS in 5/17 patients with pre-operative DDS. DDS apparently developed for the first time after bilateral STN DBS in two patients, although only after a latency of eight years in one case. One patient without reported pre-operative DDS or ICDs developed pathological gambling post-STN DBS. One patient had pathological gambling which resolved pre-operatively, and did not recur post-DBS. Thus, DDS, ICDs and punding may persist, worsen or develop for the first time after DBS surgery, although a minority of patients improved dramatically. Predictive factors may include physician vigilance, motor outcome and patient compliance.
- Published
- 2009
- Full Text
- View/download PDF
4. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.
- Author
-
O'Sullivan SS, Evans AH, and Lees AJ
- Subjects
- Clinical Trials as Topic, Cognition, Humans, Reward, Risk Factors, Substance-Related Disorders epidemiology, Substance-Related Disorders physiopathology, Substance-Related Disorders therapy, Syndrome, Dopamine metabolism, Dopamine Agonists adverse effects, Iatrogenic Disease, Parkinson Disease complications, Parkinson Disease drug therapy, Substance-Related Disorders complications
- Abstract
Dopamine dysregulation syndrome (DDS) is a relatively recently described iatrogenic disturbance that may complicate long-term symptomatic therapy of Parkinson's disease. Patients with DDS develop an addictive pattern of dopamine replacement therapy (DRT) use, administering doses in excess of those required to control their motor symptoms. The prevalence of DDS in patients attending specialist Parkinson's disease centres is 3-4%. Amongst the behavioural disturbances associated with DDS are punding, which is a complex stereotyped behaviour, and impulse control disorders (ICDs), such as pathological gambling, hypersexuality, compulsive shopping and compulsive eating. We review the risk factors and potential mechanisms for the development of DDS, including personality traits, potential genetic influences and Parkinson's disease-related cognitive deficits. Impulsive personality traits are prominent in patients developing DDS, and have been previously associated with the development of substance dependence. Candidate genes affecting the dopamine 'D(2)-like' receptor family have been associated with impulsive personality traits in addition to drug and nondrug addictions. Impaired decision making is implicated in addictive behaviours, and decision-making abilities can be influenced by dopaminergic medications. In Parkinson's disease, disruption of the reciprocal loops between the striatum and structures in the prefrontal cortex following dopamine depletion may predispose to DDS. The role of DRT in DDS is discussed, with particular reference to models of addiction, suggesting that compulsive drug use is due to progressive neuroadaptations in dopamine projections to the accumbens-related circuitry. Evidence for neuroadaptations and sensitization occurring in DDS include enhanced levodopa-induced ventral striatal dopamine release. Levodopa is still considered the most potent trigger for DDS in Parkinson's disease, but subcutaneous apomorphine and oral dopamine agonists may also be responsible. In the management of DDS, further research is needed to identify at-risk groups, thereby facilitating more effective early intervention. Therefore, an increased awareness of the syndrome amongst treating physicians is vital. Medication reduction strategies are employed, particularly with regard to avoiding rapidly acting 'booster' DRT formulations. Psychosocial treatments, including cognitive-behavioural therapy, have been beneficial in treating substance use disorders and ICDs in non-Parkinson's disease patients, but there are currently no published trials of psychological interventions in DDS. Further studies are also required to identify factors that can predict those patients with DDS or ICDs who will derive benefit from surgical interventions such as deep brain stimulation.
- Published
- 2009
- Full Text
- View/download PDF
5. Punding in Parkinson's disease.
- Author
-
O'Sullivan SS, Evans AH, and Lees AJ
- Subjects
- Adult, Antiparkinson Agents adverse effects, Antipsychotic Agents therapeutic use, Brain drug effects, Brain metabolism, Dopamine Agonists adverse effects, Humans, Impulsive Behavior physiopathology, Impulsive Behavior psychology, Male, Mental Disorders physiopathology, Mental Disorders psychology, Obsessive-Compulsive Disorder etiology, Obsessive-Compulsive Disorder physiopathology, Obsessive-Compulsive Disorder psychology, Parkinson Disease physiopathology, Parkinson Disease psychology, Brain physiopathology, Dopamine metabolism, Impulsive Behavior etiology, Mental Disorders etiology, Parkinson Disease complications
- Published
- 2007
- Full Text
- View/download PDF
6. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.
- Author
-
Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, and Schrag A
- Subjects
- Adult, Aged, Chi-Square Distribution, Female, Humans, Male, Middle Aged, Odds Ratio, Parkinson Disease drug therapy, Prospective Studies, Reaction Time drug effects, Retrospective Studies, Risk Factors, Dopamine metabolism, Dopamine Agonists adverse effects, Gambling, Levodopa adverse effects, Parkinson Disease psychology
- Abstract
Pathological gambling (PG) has been reported as a complication of the treatment of Parkinson's disease (PD). We examined all published cases of PG for prevalence and risk factors of this complication, the relationship of PG and use of dopamine agonists (DA), and the relationship of PG to the dopamine dysregulation syndrome (DDS). The prevalence of PG in prospective studies of PD patients using DA has been reported between 2.3 and 8%, compared to approximately 1% in the general population. As in the general population, PD patients with this complication are often young, male and have psychiatric co-morbidity. The vast majority are on DA, often at maximum dose or above. Differences between oral DA failed to reach significance. PG associated with levodopa monotherapy is uncommon, but in the majority of cases levodopa is co-prescribed, suggesting possible cross-sensitization of brain systems mediating reward. PG can occur with DDS but often occurs in isolation. In contrast to DDS, escalation and self regulation of anti-parkinsonian medication are not usually seen. PG in patients with PD using DA is higher than PG reported in the general population, but shares similar characteristics and risk factors. PG is predominantly associated with oral DA. It often occurs in isolation and may not be associated with DDS, which typically occurs on treatment with levodopa or subcutaneous apomorphine., ((c) 2007 Movement Disorder Society.)
- Published
- 2007
- Full Text
- View/download PDF
7. Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
- Author
-
Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, Brooks DJ, Lees AJ, and Piccini P
- Subjects
- Aged, Brain Mapping, Dopamine Agents pharmacology, Dopamine Antagonists, Exploratory Behavior drug effects, Female, Humans, Levodopa pharmacology, Male, Middle Aged, Positron-Emission Tomography, Psychological Tests, Raclopride, Receptors, Dopamine D2 drug effects, Receptors, Dopamine D3 drug effects, Substance-Related Disorders psychology, Synaptic Transmission physiology, Dopamine physiology, Neostriatum physiology, Substance-Related Disorders physiopathology
- Abstract
Objective: A small group of Parkinson's disease (PD) patients compulsively use dopaminergic drugs despite causing harmful social, psychological, and physical effects and fulfil core Diagnostic and Statistical Manual (of Mental Disorders) Fourth Edition criteria for substance dependence (dopamine dysregulation syndrome [DDS]). We aimed to evaluate levodopa-induced dopamine neurotransmission in the striatum of patients with DDS compared with PD control patients., Methods: We used a two-scan positron emission tomography protocol to calculate the percentage change in (11)C-raclopride binding potential from a baseline withdrawal (off drug) state to the binding potential after an oral dose of levodopa. We related the subjective effects of levodopa to the effects on endogenous dopamine release of a pharmacological challenge with levodopa in eight control PD patients and eight patients with DDS., Results: PD patients with DDS exhibited enhanced levodopa-induced ventral striatal dopamine release compared with levodopa-treated patients with PD not compulsively taking dopaminergic drugs. The sensitized ventral striatal dopamine neurotransmission produced by levodopa in these individuals correlated with self-reported compulsive drug "wanting" but not "liking" and was related to heightened psychomotor activation (punding)., Interpretation: This provides evidence that links sensitization of ventral striatal circuitry in humans to compulsive drug use.
- Published
- 2006
- Full Text
- View/download PDF
8. Dopamine dysregulation syndrome in Parkinson's disease.
- Author
-
Evans AH and Lees AJ
- Subjects
- Animals, Basal Ganglia drug effects, Basal Ganglia metabolism, Basal Ganglia physiopathology, Humans, Mental Disorders metabolism, Mental Disorders physiopathology, Parkinson Disease drug therapy, Reward, Substance-Related Disorders metabolism, Ventral Tegmental Area metabolism, Ventral Tegmental Area physiopathology, Antiparkinson Agents adverse effects, Dopamine metabolism, Dopamine Agonists adverse effects, Mental Disorders chemically induced, Substance-Related Disorders physiopathology, Ventral Tegmental Area drug effects
- Abstract
Purpose of Review: Dopamine replacement therapy in Parkinson's disease ameliorates motor symptoms. However, it has recently been recognized that a small sub-group of patients suffer motor and behavioural disturbances attributable to taking quantities of medication well beyond the dose required to treat their motor disabilities. This review examines the phenomenology of dopamine dysregulation syndrome in relation to the current understanding of basal ganglia function and its impact on long-term management., Recent Findings: Cortico-striato-thalamic circuits are implicated in the behavioural and motor disturbances associated with compulsive medication use in Parkinson's disease. Advances in understanding of the role of dopamine in psychostimulant addiction are important in helping to understand dopamine dysregulation., Summary: Recognition of dopamine dysregulation syndrome and characterization of its phenomenology supports the notion that the medication used to treat Parkinson's disease can disrupt basal ganglia mediated motor and behavioural functioning. Refinement of clinical strategies to predict, identify and manage this syndrome will aid the future treatment of motor and non-motor complications of Parkinson's disease.
- Published
- 2004
- Full Text
- View/download PDF
9. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.
- Author
-
Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, and Lees AJ
- Subjects
- Aged, Cognition Disorders diagnosis, Dopamine therapeutic use, Dopamine Agonists classification, Dopamine Agonists therapeutic use, Female, Humans, Injections, Subcutaneous, Levodopa therapeutic use, Male, Middle Aged, Neuropsychological Tests, Obsessive-Compulsive Disorder psychology, Occupations, Parkinson Disease drug therapy, Stereotyped Behavior, Videotape Recording, Dopamine metabolism, Parkinson Disease metabolism, Parkinson Disease physiopathology
- Abstract
Punding is a term that was coined originally to describe complex prolonged, purposeless, and stereotyped behaviour in chronic amphetamine users. A structured interview of 50 patients with higher dopamine replacement therapy requirements (>800 levodopa equivalent units/day) from 123 unselected patients with Parkinson's disease (PD) from a PD clinic identified 17 (14%) patients with punding. Punding was acknowledged as disruptive and unproductive by the patients themselves, but forcible attempts by family to interrupt the behaviour led to irritability and dysphoria. Punding was associated with very high doses of dopamine replacement therapy often related to a pattern of chronic inappropriate overuse of dopaminergic medication. We believe that this is an underreported, socially disabling phenomenon that is commonly associated with the syndrome of dopamine dysregulation and is phenomenologically distinct from both obsessive-compulsive disorder and mania., (Copyright 2004 Movement Disorder Society)
- Published
- 2004
- Full Text
- View/download PDF
10. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?
- Author
-
Lawrence AD, Evans AH, and Lees AJ
- Subjects
- Disease Management, Dopamine adverse effects, Humans, Models, Biological, Movement Disorders etiology, Parkinson Disease physiopathology, Reward, Substance-Related Disorders, Dopamine therapeutic use, Movement Disorders therapy, Parkinson Disease therapy
- Abstract
Dopamine replacement therapy (DRT) is the most effective treatment for Parkinson's disease (PD); it provides substantial benefit for most patients, extends independence, and increases survival. A few patients with PD, however, take increasing quantities of medication far beyond those required to treat their motor disabilities. These patients demand rapid drug escalation and continue to request more DRT despite the emergence of increasingly severe drug-induced motor complications and harmful behavioural consequences. In this article we detail the features of compulsive DRT-seeking and intake in PD, in relation to theories of compulsive drug use.
- Published
- 2003
- Full Text
- View/download PDF
11. Impulse Control and Related Disorders in Parkinson's Disease.
- Author
-
Lim, Shen‐Yang, Evans, Andrew H., and Miyasaki, Janis M.
- Subjects
- *
PARKINSON'S disease , *IMPULSE control disorders , *PATHOLOGICAL psychology , *DOPAMINE , *DOPAMINE agonists , *PUBLIC health , *INFECTIOUS disease transmission , *DISEASES , *EPIDEMIOLOGY - Abstract
In the past decade, impulse control disorders, punding, and dopamine dysregulation syndrome (which we refer to collectively as disinhibitory psychopathologies) have been increasingly recognized in treated patients with Parkinson's disease. Practicing neurologists must understand these problems to limit potential harm. In this article, we summarize current knowledge regarding these behavioral disorders, including phenomenology, epidemiology, pathophysiology, and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.